1. Apoptotic signaling in salivary mucoepidermoid carcinoma
   Gabriela M. da Silva et al, 2019, Head & Neck CrossRef
2. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructose-responsive manner promotes pancreatic cancer metastasis
   Chi-Che Hsieh et al, 2017, Oncotarget CrossRef
3. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio
   Ming-Hsien Chien et al, 2017, Molecular Cancer Therapeutics CrossRef
4. Prognostic Investigations of Expression Level of Two Genes FasL and Ki-67 as Independent Prognostic Markers of Human Retinoblastoma
   Samaneh Kouzegaran et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
5. The role of CD95 and CD95 ligand in cancer
   M E Peter et al, 2015, Cell Death & Differentiation CrossRef
6. Prognostic markers in esophageal cancer: from basic research to clinical use
   Liu Hong et al, 2015, Expert Review of Gastroenterology & Hepatology CrossRef
7. Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer
   Maria A. Papadaki et al, 2024, Cancers CrossRef
8. The effect of Fas/FasL pathway blocking on apoptosis and stemness within breast cancer tumor microenvironment (preclinical study)
   Seham Abou Shousha et al, 2023, Breast Disease CrossRef
9. MicroRNA and target mRNA selection through invasion and cytotoxicity cell modeling and bioinformatics approaches in esophageal squamous cell carcinoma
   Mu Lu et al, 2017, Oncology Reports CrossRef